scholarly journals Extracorporeal Membrane Oxygenation for ARDS: National Trends in the United States 2008–2012

2016 ◽  
Vol 61 (10) ◽  
pp. 1293-1298 ◽  
Author(s):  
Bhupinder S Natt ◽  
Hem Desai ◽  
Nirmal Singh ◽  
Chithra Poongkunran ◽  
Sairam Parthasarathy ◽  
...  
Keyword(s):  
United States ◽  
Extracorporeal Membrane Oxygenation ◽  
The United States ◽  
Membrane Oxygenation ◽  
National Trends

National trends in neonatal extracorporeal membrane oxygenation in the United States

2018 ◽  
Vol 38 (8) ◽  
pp. 1106-1113 ◽  
Author(s):  
Parth Bhatt ◽  
Anusha Lekshminarayanan ◽  
Keyur Donda ◽  
Fredrick Dapaah-Siakwan ◽  
Achint Patel ◽  
...  
Keyword(s):  
United States ◽  
Extracorporeal Membrane Oxygenation ◽  
The United States ◽  
Membrane Oxygenation ◽  
National Trends

Utilization patterns of extracorporeal membrane oxygenation in neonates in the United States 1997–2012

2017 ◽  
Vol 52 (10) ◽  
pp. 1681-1687 ◽  
Author(s):  
Ashley Y. Song ◽  
Hsuan-Hsiu Annie Chen ◽  
Rachel Chapman ◽  
Ameish Govindarajan ◽  
Jeffrey S. Upperman ◽  
...  
Keyword(s):  
United States ◽  
Extracorporeal Membrane Oxygenation ◽  
The United States ◽  
Membrane Oxygenation ◽  
Utilization Patterns

Three consecutive cases of fatal intraoperative intracardiac thrombosis associated with the initiation of venoarterial extracorporeal membrane oxygenation in the presence of aprotinin

Perfusion ◽  
2019 ◽  
Vol 34 (5) ◽  
pp. 417-421 ◽  
Author(s):  
Chris Oscier ◽  
Chinmay Patvardhan ◽  
Florian Falter ◽  
Will Tosh ◽  
John Dunning ◽  
...  
Keyword(s):  
United States ◽  
Cardiac Surgery ◽  
Extracorporeal Membrane Oxygenation ◽  
Hospital Mortality ◽  
Cardiogenic Shock ◽  
Bleeding Risk ◽  
The United States ◽  
Membrane Oxygenation ◽  
Venoarterial Extracorporeal Membrane Oxygenation ◽  
Intracardiac Thrombosis

Central venoarterial extracorporeal membrane oxygenation has been used since the 1970s to support patients with cardiogenic shock following cardiac surgery. Despite this, in-hospital mortality is still high, and although rare, thrombus within the cardiac chambers or within the extracorporeal membrane oxygenation circuit is often fatal. Aprotinin is an antifibrinolytic available in Europe and Canada, though not currently in the United States. Due to historical safety concerns, use of aprotinin is generally limited and is commonly reserved for patients with the highest bleeding risk. Given the limited availability of aprotinin over the last decade, it is not surprising to find a complete absence of literature describing the use of venoarterial extracorporeal membrane oxygenation in the presence of aprotinin. We present three consecutive cases of rapid fatal intraoperative intracardiac thrombosis associated with post-cardiotomy central venoarterial extracorporeal membrane oxygenation in patients receiving aprotinin.

scholarly journals Contemporary look at extracorporeal membrane oxygenation as a bridge to reoperative lung transplantation in the United States – a retrospective study

2020 ◽  
Vol 33 (8) ◽  
pp. 895-901 ◽  
Author(s):  
Jeremiah William Awori Hayanga ◽  
Heather K. Hayanga ◽  
James H. Fugett ◽  
Kelsey A. Musgrove ◽  
Ghulam Abbas ◽  
...  
Keyword(s):  
United States ◽  
Retrospective Study ◽  
Extracorporeal Membrane Oxygenation ◽  
Lung Transplantation ◽  
The United States ◽  
Membrane Oxygenation

scholarly journals Trends in Extracorporeal Membrane Oxygenation for the Treatment of Acute Respiratory Distress Syndrome in the United States

2016 ◽  
Vol 32 (9) ◽  
pp. 535-539 ◽  
Author(s):  
Barret Rush ◽  
Katie Wiskar ◽  
Landon Berger ◽  
Donald Griesdale
Keyword(s):  
United States ◽  
Acute Respiratory Distress Syndrome ◽  
Extracorporeal Membrane Oxygenation ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Distress Syndrome ◽  
International Classification Of Diseases ◽  
The United States ◽  
Relative Increase ◽  
Membrane Oxygenation

Objectives: Our aim was to describe patient characteristics and trends in the use of extracorporeal membrane oxygenation (ECMO) for the treatment of acute respiratory distress syndrome (ARDS) in the United States from 2006 to 2011. Methods: We used the Nationwide Inpatient Sample to isolate all patients aged 18 years who had a discharge International Classification of Diseases, Ninth Revision diagnosis of ARDS, with and without procedure codes for ECMO, between 2006 and 2011. Results: We examined a total of 47 911 414 hospital discharges, representing 235 911 271 hospitalizations using national weights. Of the 1 479 022 patients meeting the definition of ARDS (representing 7 281 206 discharges), 775 underwent ECMO. There was a 409% relative increase in the use of ECMO for ARDS in the United States between 2006 and 2011, from 0.0178% to 0.090% ( P = .0041). Patients treated with ECMO had higher in-hospital mortality (58.6% vs 25.1%, P < .0001) and longer hospital stays (15.8 days vs 6.9 days, P < .0001). They were also younger (47.9 vs 66.4 years, P < .0001) and more likely to be male (62.2% vs 49.6%, P < .0001). The median time to initiate ECMO from the time of admission was 0.5 days (interquartile range [IQR] 4.9 days). Conclusion: There has been a dramatic increase in ECMO use for the treatment of ARDS in the United States.

The changing population of the United States and use of extracorporeal membrane oxygenation

2013 ◽  
Vol 184 (1) ◽  
pp. 572-576 ◽  
Author(s):  
Faisal G. Qureshi ◽  
Hope T. Jackson ◽  
Jessica Brown ◽  
Mikael Petrosyan ◽  
Peter T. Rycus ◽  
...  
Keyword(s):  
United States ◽  
Extracorporeal Membrane Oxygenation ◽  
The United States ◽  
Membrane Oxygenation
Sign in / Sign up

Export Citation Format

Share Document